AIR DNase
PB-110-CF01
Phase 1 small_molecule completed
Quick answer
AIR DNase for Cystic Fibrosis (CF) is a Phase 1 program (small_molecule) at Protalix BioTherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protalix BioTherapeutics
- Indication
- Cystic Fibrosis (CF)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed